Physician profile
Claude B Scott
NPI 1720063944
$5,543.35
in general payments reported to CMS, 2019-2025
11 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $364 · 2021: $276 · 2022: $473 · 2023: $3,721 · 2024: $128 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,034 · Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,033.65 |
| Food and Beverage | $1,105.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,742.54 | 2023 | |
| Medical Device Business Services, INC. | $1,656.65 | 2023 | Na |
| Stryker Corporation | $932.21 | 2019-2024 | Vitoss, Bio4, Axsos |
| Depuy Synthes Sales INC. | $416.62 | 2019-2025 | Na, Lcp, Motoband |
| Heron Therapeutics, INC. | $247.43 | 2022 | |
| Sanara Medtech INC. | $194.08 | 2023 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $146.63 | 2022 | |
| Integra Lifesciences Corporation | $127.99 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nuvasive, INC. | $37.02 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $27.53 | 2025 | |
| Endo Pharmaceuticals INC. | $14.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claude Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.